TY - JOUR
T1 - The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study
AU - Kjeldsen, SE
AU - Lyle, PA
AU - Kizer, JR
AU - Dahlof, B
AU - Devereux, RB
AU - Julius, S
AU - Beevers, David
AU - de Faire, U
AU - Fyhrquist, F
AU - Ibsen, H
AU - Kristianson, K
AU - Lederballe-Pedersen, O
AU - Lindholm, JH
AU - Nieminen, MS
AU - Omvik, P
AU - Oparil, S
AU - Snappin, S
AU - Harris, KE
AU - Wedel, H
PY - 2005/3/1
Y1 - 2005/3/1
N2 - The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study reported that a losartan-based antihypertensive regimen reduced cardiovascular morbidity and mortality (composite of cardiovascular death, stroke, and myocardial infarction) more than therapy based on atenolol in patients with left ventricular hypertrophy and isolated systolic hypertension (ISH). Patients aged 55-80 years with blood pressures 160-200/
AB - The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study reported that a losartan-based antihypertensive regimen reduced cardiovascular morbidity and mortality (composite of cardiovascular death, stroke, and myocardial infarction) more than therapy based on atenolol in patients with left ventricular hypertrophy and isolated systolic hypertension (ISH). Patients aged 55-80 years with blood pressures 160-200/
UR - http://www.scopus.com/inward/record.url?scp=20644466411&partnerID=8YFLogxK
U2 - 10.1111/j.1524-6175.2005.04254.x
DO - 10.1111/j.1524-6175.2005.04254.x
M3 - Article
C2 - 15785156
SN - 1751-7176
VL - 7
SP - 152
EP - 158
JO - Journal of Clinical Hypertension
JF - Journal of Clinical Hypertension
ER -